Month: December 2020

WILMINGTON, N.C., Dec. 07, 2020 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced its participation in the following investor conference:Barclays Global Technology, Media and Telecommunications ConferencePresentation: Thursday, December 10th, 2020 at 9:00am ETA live webcast, as well as a replay, will be available on the company’s investor relations website at https://investor.ncino.com/news-events/events-and-presentationsAbout nCinonCino (NASDAQ: NCNO) is the worldwide leader in cloud banking. The nCino Bank Operating System® empowers financial institutions with scalable technology to help them achieve revenue growth, greater efficiency, cost savings and regulatory compliance. In a digital-first world, nCino’s...

ST. LOUIS, Dec. 07, 2020 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced that Vodafone Romania and Amdocs partnered to jointly develop the Digital Experience platform for digitalizing the retail experience. This will give Vodafone Romania a 360-degree view of its customers across a number of touch-points while integrating fixed and mobile communication products into a converged retail product. The project included moving several key components and capabilities into the AWS cloud.The project is a key milestone in Vodafone Romania’s journey towards a technology communications company where strong internal software engineering capabilities enabled a new partnership model with Amdocs. Through the digital transformation of its retail experience,...

THORNTON, CO, Dec. 07, 2020 (GLOBE NEWSWIRE) — via NewMediaWire – Ascent Solar Technologies, Inc. (OTCQB: ASTI), a developer and manufacturer of state-of-the-art, lightweight, and flexible thin-film photovoltaic (PV) solutions, announces new Board of Directors composition and Chief Financial Officer.The Company has appointed David Peterson as a Class 3 director to be effective as of December 10, 2020. Mr. Peterson is currently the Manager of Crowdex Investment, LLC (“Crowdex”). Crowdex is the Company’s controlling stockholder through its holdings of the recently issued shares of Series 1A Preferred Stock pursuant to Form 8-K filing on September 30, 2020.From April 2015 to present, Mr. Peterson has worked for EPD Consultants, Inc., a privately held engineering firm headquartered in Carson, California, where he serves as Senior Project...

METTAWA, Ill., Dec. 07, 2020 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE:BC) has been named by Newsweek to the 2021 list of America’s Most Responsible Companies.  From the thousands of companies considered for this honor, only 400 made the final list and Brunswick is ranked No. 205 overall.“We are honored to be named to the list of America’s Most Responsible Companies by Newsweek,” said Brenna Preisser, President – Business Acceleration & Chief People and Strategy Officer.  “This award recognizes our commitment to corporate social responsibility and the efforts our Company is leading to make a positive difference in our communities.   As an industry leader, advancing innovation and inspiration on the water, our customers and employees look to us to set a standard when it comes to corporate citizenship and governance...

Fleming Island, Florida, Dec. 07, 2020 (GLOBE NEWSWIRE) — OBITX, Inc. (OTC MARKET: OBITX) is pleased to announce the conversion of its Revolving Credit Agreement into common shares of the Company’s stock.  The conversion of the nearly $100K in debt was at the price of $2.50 per share.  In further action, two warrant holders have exercised $55K in warrants previously registered by the Company.  The Company’s recent activity is consistent with the development of the Company’s business growth and strategy, as it projects to announce within the next week its recent quarter’s results, which will show the significant growth in revenue under its recent shift in operations.  The company ability to reach agreement eliminates OBITX debt. Under the terms of the agreement the debts are fully settled, including any and all interest and fees. Michael...

NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced results presented at the 62nd annual meeting American Society of Hematology (ASH), which provide in vivo biomarker evidence linking remestemcel-L’s immunomodulatory activity to survival outcomes in children with steroid-refractory acute graft versus host disease (SR-aGVHD). The results were presented on December 6, 2020 by the Phase 3 trial’s lead investigator and pediatric transplant physician, Dr Joanne Kurtzberg, the Jerome Harris Distinguished Professor of Pediatrics and Professor of Pathology, and Director, Pediatric Blood and Marrow Transplant Program at Duke University Medical Center.Key conclusions were:Clinically meaningful overall responses and survival in...

High profile firm WireBuzz boasts relationships with Fortune 500 firms and nation’s top health care companiesIndustry leading digital marketing agency renowned for driving awareness and online businessWireBuzz poised to aid Electromedical Technologies in onboarding new distributors and customersSCOTTSDALE, Ariz., Dec. 07, 2020 (GLOBE NEWSWIRE) — Electromedical Technologies, Inc. (OTCQB: EMED ) (the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce its new strategic partnership with WireBuzz, LLC (www.wirebuzz.com), an award-winning video and web design agency. The Company elected to work with WireBuzz based upon its renowned reputation for content production, advanced marketing, and specifically, its impressive online customer...

Results support first proof of concept for HOOKIPA’s replicating investigational single-vector immunotherapy in oncologyData demonstrate responses and stable disease in some head and neck cancer patients who all received at least two prior therapies and progressed on a PD1 inhibitorBy targeting an antigen common to Human Papillomavirus 16-positive (HPV16+), HB-201 has the potential to be a tumor-agnostic therapy for all HPV16+ cancersNEW YORK and VIENNA, Austria, Dec. 07, 2020 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced positive interim Phase 1 data on HB-201, its replicating monotherapy for the treatment of HPV16+ cancers. The results are from the initial dose escalation cohorts of an ongoing...